← Back to Patent Explorer
US4332798A Expired / Lapsed US ⏱️ 0.0 years remaining

7-Amino-thia-diazole oxyimino derivatives of cephem and cephem compounds

Assignee: Astellas Pharma Inc
•
Filing: 1980-01-30
•
Granted: 1982-06-01
•
Expires: 2000-01-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 7-Substituted-3-cephem and cepham-4-carboxylic acids of formula (I) ##STR1## wherein R 1 is amino or a protected amino, R 2 is hydrogen, acyl, aryl which may be substituted with suitable substituent(s), lower alkyl substituted with suitable substituent(s), lower alkenyl, lower alkynyl, cycloalkyl which may be substituted with suitable substituent(s), cyclo(lower)alkenyl, or S- or O-containing 5-membered heterocyclic group substituted with oxo group(s). R 3 is hydrogen or lower alkyl, R 4 is hydrogen; acyloxy(lower)alkyl; acylthio(lower)alkyl pyridinium(lower)alkyl which may be substituted with suitable substituent(s); a heterocyclicthio(lower)alkyl which may be substituted with suitable substituent(s); lower alkyl; halogen; or hydroxy; and R 5 is carboxy or a protected carboxy wherein R 5 is COO-- when R 4 is pyridinium(lower)alkyl which may be substituted with suitable substituent(s), and the heavy solid line means single or double bond, have useful antibiotic properties.

Inventors

  • 👤 Tsutomu Teraji
  • 👤 Kazuo Sakane
  • 👤 Jiro Goto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 01:30
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/44; C07D209/48; C07C; C07C17/00; C07C17/26; C07C17/263; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/12; C07D257/00; C07D257/02; C07D257/04; C07D285/00; C07D285/01; C07D285/02; C07D285/04; C07D285/08; C07D295/00; C07D295/16; C07D295/20; C07D295/21

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 227 words
7-Substituted-3-cephem and cepham-4-carboxylic acid of the formula: ##STR14## where R 1 is amino or a protected amino; R 2 is hydrogen; carbamoyl; lower alkanoyl; lower alkoxycarbonyl; aroyl; ar(lower)alkanoyl; cyclo(lower)alkyl(lower)alkanoyl; ar(lower)alkoxycarbonyl; (lower)alkanesulfonyl; arenesulfonyl; aryl; alkaryl; aryl and alkaryl substituted in the aryl nucleus with 1 to 3 substituent(s) selected from the group consisting of halogen, lower alkoxy, nitro, halo(lower)alkyl, and protected carboxy; substituted lower alkyl selected from the group consisting of ar(lower)alkyl, lower alkylthio(lower)alkyl, halo(lower)alkyl, aryloxy(lower)alkyl, cyano(lower)alkyl, protected carboxy(lower)alkyl, di(lower)alkylcarbamoyl(lower)alkyl, lower alkoxy(lower)alkoxy(lower)alkyl, lower alkanesulfonyl(lower)alkyl, protected amino(lower)alkyl, amino(lower)alkyl, carboxy(lower)alkyl, ar(lower)alkyl substituted with protected carboxy, ar(lower)alkyl substituted with carboxy, ar(lower)alkyl substituted with protected amino(lower)alkyl, and ar(lower)alkyl substituted with amino(lower)alkyl; lower alkenyl; lower alkynyl; cycloalkyl; cycloalkyl substituted with carboxy or protected carboxy; cyclo(lower)alkenyl; or S or O containing 5-membered heterocyclic group substituted with oxo group(s); R 3 is hydrogen or lower alkyl; R 4 is hydrogen; acyloxy(lower)alkyl; acylthio(lower)alkyl; pyridinium(lower)alkyl; pyridinium(lower)alkyl substituted with carbamoyl; heterocyclicthio(lower)alkyl; heterocyclicthio(lower)alkyl substituted with 1 to 3 substituent(s) selected from the group consisting of lower alkyl, hydroxy(lower)alkyl, protected amino(lower)alkyl, amino(lower)alkyl, di(lower)alkylamino(lower)alkyl, lower alkenyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, aryl, morpholino(lower)alkyl, piperidino(lower)alkyl, lower alkyl substituted piperazinyl(lower)alkyl, oxo and hydroxy; lower alkyl; halogen; or hydroxy; R 5 is carboxy or a protected carboxy; wherein R 5 is COO - when R 4 is pyridinium(lower)alkyl or substituted pyridinium(lower)alkyl; and the heavy solid line means single or double bond; and pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 227 words
7-Substituted-3-cephem and cepham-4-carboxylic acid of the formula: ##STR14## where R 1 is amino or a protected amino; R 2 is hydrogen; carbamoyl; lower alkanoyl; lower alkoxycarbonyl; aroyl; ar(lower)alkanoyl; cyclo(lower)alkyl(lower)alkanoyl; ar(lower)alkoxycarbonyl; (lower)alkanesulfonyl; arenesulfonyl; aryl; alkaryl; aryl and alkaryl substituted in the aryl nucleus with 1 to 3 substituent(s) selected from the group consisting of halogen, lower alkoxy, nitro, halo(lower)alkyl, and protected carboxy; substituted lower alkyl selected from the group consisting of ar(lower)alkyl, lower alkylthio(lower)alkyl, halo(lower)alkyl, aryloxy(lower)alkyl, cyano(lower)alkyl, protected carboxy(lower)alkyl, di(lower)alkylcarbamoyl(lower)alkyl, lower alkoxy(lower)alkoxy(lower)alkyl, lower alkanesulfonyl(lower)alkyl, protected amino(lower)alkyl, amino(lower)alkyl, carboxy(lower)alkyl, ar(lower)alkyl substituted with protected carboxy, ar(lower)alkyl substituted with carboxy, ar(lower)alkyl substituted with protected amino(lower)alkyl, and ar(lower)alkyl substituted with amino(lower)alkyl; lower alkenyl; lower alkynyl; cycloalkyl; cycloalkyl substituted with carboxy or protected carboxy; cyclo(lower)alkenyl; or S or O containing 5-membered heterocyclic group substituted with oxo group(s); R 3 is hydrogen or lower alkyl; R 4 is hydrogen; acyloxy(lower)alkyl; acylthio(lower)alkyl; pyridinium(lower)alkyl; pyridinium(lower)alkyl substituted with carbamoyl; heterocyclicthio(lower)alkyl; heterocyclicthio(lower)alkyl substituted with 1 to 3 substituent(s) selected from the group consisting of lower alkyl, hydroxy(lower)alkyl, protected amino(lower)alkyl, amino(lower)alkyl, di(lower)alkylamino(lower)alkyl, lower alkenyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, aryl, morpholino(lower)alkyl, piperidino(lower)alkyl, lower alkyl substituted piperazinyl(lower)alkyl, oxo and hydroxy; lower alkyl; halogen; or hydroxy; R 5 is carboxy or a protected carboxy; wherein R 5 is COO - when R 4 is pyridinium(lower)alkyl or substituted pyridinium(lower)alkyl; and the heavy solid line means single or double bond; and pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 7 words
Syn-isomer of a compound of claim 1.
Claim 4
Dependent Claim 13 words
A compound of claim 2, wherein the heavy solid line is double bond.
Claim 5
Dependent Claim 220 words
A compound of claim 3, wherein R 1 is amino; R 2 is hydrogen; aryl; alkaryl; aryl and alkaryl substituted in the aryl nucleus with 1 to 3 substituent(s) selected from the group consisting of halogen, lower alkoxy, nitro, halo(lower)alkyl and protected carboxy; ar(lower)alkyl; lower alkylthio(lower)alkyl; halo(lower)alkyl; aryloxy(lower)alkyl; cyano(lower)alkyl; protected carboxy(lower)alkyl; di(lower)alkylcarbamoyl(lower)alkyl; lower alkoxy(lower)alkoxy(lower)alkyl; lower alkanesulfonyl(lower)alkyl; protected amino(lower)alkyl; amino(lower)alkyl; carboxy(lower)alkyl; ar(lower)alkyl substituted with protected carboxy; ar(lower)alkyl substituted with carboxy; ar(lower)alkyl substituted with protected amino(lower)alkyl; ar(lower)alkyl substituted with amino(lower)alkyl; lower alkenyl; lower alkynyl; cycloalkyl; cycloalkyl substituted with carboxy or protected carboxy; cyclo(lower)alkenyl; thiolanyl substituted with 2 oxo groups; or tetrahydrofuryl substituted with oxo group; R 4 is hydrogen, acyloxy(lower)alkyl; pyridinium(lower)alkyl substituted with carbamoyl; thiadiazolyl thio(lower)alkyl; thiadiazolylthio(lower)alkyl substituted with a substituent selected from the group consisting of lower alkyl, hydroxy(lower)alkyl, protected amino(lower)alkyl and amino(lower)alkyl; tetrazolylthio(lower)alkyl; tetrazolythio(lower)alkyl substituted with a substituent selected from the group consisting of lower alkyl, hydroxy(lower)alkyl, amino(lower)alkyl, protected amino(lower)alkyl, di(lower)alkylamino(lower)alkyl, lower alkenyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, aryl, morpholino(lower)alkyl, piperidino(lower)alkyl and lower alkyl substituted piperazinyl(lower)alkyl; tetrazolopyridazinylthio(lower)alkyl; dihydrotriazolopyridazinylthio(lower)alkyl substituted with oxo and carboxy(lower)alkyl; dihydrotriazinylthio(lower)alkyl substituted with oxo, hydroxy and lower alkyl; lower alkyl; or halogen; and R 5 is carboxy; ar(lower)alkoxycarbonyl substituted with nitro; lower alkanoyloxy(lower)alkoxycarbonyl; lower alkoxy carbonyloxy(lower)alkoxy carbonyl; lower alkoxycarbonyloxy(lower)alkoxycarbonyl substituted with azido; aroyloxy(lower)alkoxycarbonyl; or phthalidyloxycarbonyl; wherein R 5 is COO - when R 4 is pyridinium(lower)alkyl substituted with carbamoyl.
Claim 6
Dependent Claim 56 words
A compound of claim 4, wherein R 2 is carboxy(lower)alkyl, cycloalkyl or cyclo(lower)alkenyl, R 3 is hydrogen, R 4 is hydrogen, thiadiazolylthio(lower)alkyl, tetrazolylthio(lower)alkyl substituted with a lower alkyl or an amino(lower)alkyl, tetrazolopyridazinylthio(lower)alkyl or pyridinium(lower)alkyl substituted with carbamoyl, and R 5 is carboxy, wherein R 5 is COO - when R 4 is pyridinium(lower)alkyl substituted with carbamoyl.
Claim 7
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-cyclopentyloxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-cephem-4-carboxylic acid (syn isomer).
Claim 8
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(-cyclopenten-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-cephem-4-carboxylic acid (syn isomer).
Claim 9
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclohexen-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-cephem-4-carboxylic acid (syn isomer).
Claim 10
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(1-carboxyethoxyimino)-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-cephem-4-carboxylic acid (syn isomer).
Claim 11
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-cyclopentyloxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 12
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclopenten-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 13
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclohexen-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 14
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-cyclopentyloxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 15
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclopenten-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 16
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclohexen-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 17
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(1-carboxyethoxyimino)-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-[1-(3-aminopropyl)-1H-tetrazol-5-yl]thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 18
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-cyclopentyloxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(tetrazolo[1,5-b]pyridazin-6-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 19
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclopenten-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(tetrazolo[1,5-b]-pyridazin-6-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 20
Dependent Claim 11 words
A compound of claim 5 which is 7-[2-(2-cyclohexen-1-yl)oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido]-3-(tetrazolo[1,5-b]-pyridazin-6-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer).
Claim 21
Dependent Claim 10 words
A compound of claim 5 which is N-[7-2-cyclopentyloxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido-3-cephem-3-ylmethyl]-4'-carbamoylpyridinium-4-carboxylate (syn isomer).
Claim 22
Dependent Claim 10 words
A compound of claim 5 which is N-[7-(2-(2-cyclopenten-1-yl-oxyimino)-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido)-3-cephem-3-ylmethyl]-4'-carbamoyl-pyridinium-4-carboxylate (syn isomer).
Claim 23
Dependent Claim 10 words
A compound of claim 5 which is N-(7-(2-(1-methyl-1-carboxyethoxyimino)-2-(5-amino-1,2,4-thiadiazol-3-yl)acetamido)-3-cephem-3-ylmethyl)-4'-carbamoylpyridinium-4-carboxylate (syn isomer).
Claim 24
Dependent Claim 29 words
An antibacterial composition comprising an effective amount of a compound of claim 1 or pharmaceutically acceptable salt thereof in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient.

References Cited (Backward Citations)

US4093803A Cited
US4098888A Cited
DE2745246A1 Cited
US4263291A Cited
US4268509A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-31 1985-11-30 1986-06-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-31 1989-11-30 1990-06-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-31 1993-11-30 1994-06-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag